Isofol Medical AB Statistics

Total Valuation

Isofol Medical AB has a market cap or net worth of SEK 388.44 million. The enterprise value is 284.42 million.

Market Cap	388.44M
Enterprise Value	284.42M

Important Dates

The next estimated earnings date is Wednesday, February 19, 2025.

Earnings Date	Feb 19, 2025
Ex-Dividend Date	n/a

Share Statistics

Isofol Medical AB has 161.52 million shares outstanding. The number of shares has decreased by -4.44% in one year.

Current Share Class	n/a
Shares Outstanding	161.52M
Shares Change (YoY)	-4.44%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	22.04%
Owned by Institutions (%)	16.20%
Float	125.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	4.27
P/TBV Ratio	4.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.24
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.98

Current Ratio	5.98
Quick Ratio	5.79
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4,363.50

Financial Efficiency

Return on equity (ROE) is -35.48% and return on invested capital (ROIC) is -24.64%.

Return on Equity (ROE)	-35.48%
Return on Assets (ROA)	-20.96%
Return on Capital (ROIC)	-24.64%
Revenue Per Employee	n/a
Profits Per Employee	-9.82M
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +319.72% in the last 52 weeks. The beta is 2.04, so Isofol Medical AB's price volatility has been higher than the market average.

Beta (5Y)	2.04
52-Week Price Change	+319.72%
50-Day Moving Average	3.08
200-Day Moving Average	1.97
Relative Strength Index (RSI)	39.16
Average Volume (20 Days)	670,834

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	-37.30M
Operating Income	-43.64M
Pretax Income	-39.27M
Net Income	-39.27M
EBITDA	-43.63M
EBIT	-43.64M
Earnings Per Share (EPS)	-0.25

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	104.02M
Total Debt	n/a
Net Cash	104.02M
Net Cash Per Share	0.64
Equity (Book Value)	91.05M
Book Value Per Share	0.56
Working Capital	91.67M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-39.78M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Isofol Medical AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	4.44%
Shareholder Yield	4.44%
Earnings Yield	-10.41%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Isofol Medical AB has an Altman Z-Score of -8.78. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.78
Piotroski F-Score	n/a